-
Obamacare preventive protection of most cancers, diabetes, HIV struck by decide
A pharmacist writes a prescription in New York City. Yvonne Hemsey | Hulton Archives | Getty Images A federal judge on Thursday struck down an Obamacare mandate that requires most private health insurance plans to offer free screening services, which include everything from screening for certain types of cancer and diabetes to drugs used to…
-
Due courtroom circumstances can rule on the legality of mifepristone
Two federal judges are poised to soon issue rulings in dueling cases that could dramatically affect access to the abortion pill mifepristone. In Washington state, US District Judge Thomas Rice is considering whether to scrap federal regulations on mifepristone that make access difficult even when abortion is legal. He’s also considering issuing an injunction that…
-
Labcorp to pay $2.1 million to settle Division of Protection lawsuit
The Laboratory Corporation of America will pay $2.1 million to settle allegations that it overcharged the Defense Department for genetic testing involving children and fetuses, the Justice Department announced Monday. A former Lab Corp Whistleblower-turned employee Donna Hecker-Gross sued the diagnostic testing company under the False Claims Act on behalf of the federal government in…
-
With touring nurses making $150 an hour, hospital programs are progressive
Cassie Jupin grew up wanting to be a nurse. She sought a position at St. Peter’s Health Partners Hospital in Albany, New York and landed a position in the same maternity ward where she was born. “Knowing that I can come back to work any day and work with a group of women and people…
-
BioNTech shares slide on bleak Covid vaccine gross sales outlook
Vials of the Pfizer/BioNtech coronavirus disease (COVID-19) vaccine are displayed before being used at a mobile vaccine clinic in Valparaiso, Chile, on January 3, 2022. Rodrigo Garrido | Reuters shares of BioNTech on Monday slipped more than 6% in morning trade after the German drugmaker shared a gloomy 2023 sales outlook for its jointly developed…
-
Wyoming abortion ban blocked as a consequence of Obamacare-era change
Abortion is legal again in Wyoming, oddly as a result of a state constitutional amendment pushed by anti-Obamacare conservatives more than a decade ago. Teton County District Court Judge Melissa Owens, in a ruling Wednesday, temporarily blocked enforcement of the state’s newly enacted abortion ban that went into effect Sunday. Owens’ decision pointed to a…
-
Illumina administrators acquired extra insurance coverage to shut the Grail deal
That’s what Carl Icahn claimed on Friday EnlightenmentThe company’s directors called for additional personal liability insurance before the biotech signed a $7.1 billion acquisition of cancer test developer Grail in 2021. The allegation is the latest development in a looming proxy fight between the activist investor and San Diego-based Illumina, which have traded blows over…
-
Pfizer Covid drug Paxlovid could scale back danger of lengthy Covid: research
A prescription for Pfizer’s Paxlovid tablets outside of his home in Philadelphia, Pennsylvania on April 25, 2022. (Photo by Rachel Wisniewski/For the Washington Post) Rachel Wisniewski | The Washington Post | Getty Images people who take PfizerAntiviral Covid treatment Paxlovid shortly after infection may reduce the risk of long-term Covid illness, regardless of age, vaccination…
-
Sanofi, Regeneron shares Pop, information exhibits bronchial asthma drug Dupixent can deal with COPD
A logo on the Sanofi exhibition space at the Viva Technology conference on innovation and startups at the Porte de Versailles exhibition center in Paris, France, June 15, 2022. Benoît Tessier | Reuters shares of Sanofi And Regeneron both rose more than 6% on Thursday after the pharmaceutical companies released promising data showing their jointly…
-
FDA advisers vote in opposition to efficacy of Biogen’s ALS drug
A pedestrian walks past Biogen Inc.’s headquarters in Cambridge, Massachusetts, on Monday, June 7, 2021. Adam Glanzmann | Bloomberg | Getty Images The Food and Drug Administration’s independent advisory panel voted against the effectiveness of on Wednesday biogenic ALS drug under investigation for a rare and aggressive form of the disease. The drug Tofersen was…